Stay updated on Vilazodone Safety in GAD: Clinical Trial
Sign up to get notified when there's something new on the Vilazodone Safety in GAD: Clinical Trial page.

Latest updates to the Vilazodone Safety in GAD: Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedMaintenance updates: added Revision: v3.4.2 and removed the funding status notice and prior Revision v3.4.1; these changes do not affect study content or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check23 days agoChange DetectedA site-wide government funding notice has been added, noting that the NIH Clinical Center is open and directing users to cc.nih.gov, and the page shows a new revision tag (v3.4.1) replacing v3.4.0.SummaryDifference0.3%

- Check30 days agoChange DetectedAdditions: Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0; Deletions: Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check44 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check66 days agoChange DetectedAdded a Locations section with study sites by state and updated to Revision: v3.3.3.SummaryDifference1%

- Check87 days agoChange DetectedRevision: v3.3.2 replaces the previous v3.3.1 on the page.SummaryDifference0.0%

Stay in the know with updates to Vilazodone Safety in GAD: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vilazodone Safety in GAD: Clinical Trial page.